2. Search Result
Search Result
Results for "

RIOK2

" in MedChemExpress (MCE) Product Catalog:

10

Inhibitors & Agonists

1

Recombinant Proteins

1

Antibodies

3

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-112158
    NSC139021
    1 Publications Verification

    ERGi-USU

    		 Ser/Thr Kinase Cancer
    NSC139021 (ERGi-USU) is a RIOK2 inhibitor with anticancer activity. RIOK2 can highly selectively inhibit the growth of ERG-positive cancer cells with IC50s of 30-400 nM against cell lines. RIOK2 also causes cell cycle arrest and apoptosis in glioblastoma via induction of Skp2 and Skp2-p27/p21-Cyclin E/CDK2-pRb signaling [2].
    NSC139021
  • HY-147655
    CQ211

    		Ser/Thr Kinase Cancer
    CQ211 is a potent and selective RIOK2 inhibitor with a Kd of 6.1 nM. CQ211 exhibits potent proliferation inhibition activity against multiple cancer cell lines .
    CQ211
  • HY-139893
    ERGi-USU-6 mesylate

    		Ser/Thr Kinase Cancer
    ERGi-USU-6 mesylate (Compound 7b) is an inhibitor of ERG and RIOK2 (IC50 values: 0.17 and 0.13 μM in VCaP cells, respectively). ERGi-USU-6 mesylate exhibits anticancer activity against ERG-positive prostate cancer .
    ERGi-USU-6 mesylate
  • HY-RS24774
    Riok2 Rat Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    Riok2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Riok2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Riok2 Rat Pre-designed siRNA Set A
    Riok2 Rat Pre-designed siRNA Set A
  • HY-RS18296
    Riok2 Mouse Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    Riok2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Riok2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Riok2 Mouse Pre-designed siRNA Set A
    Riok2 Mouse Pre-designed siRNA Set A
  • HY-RS11989
    RIOK2 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    RIOK2 Human Pre-designed siRNA Set A contains three designed siRNAs for RIOK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    RIOK2 Human Pre-designed siRNA Set A
    RIOK2 Human Pre-designed siRNA Set A
  • HY-156465
    RIOK2-IN-2

    		Ser/Thr Kinase Cancer
    RIOK2-IN-2 (8) is a RIOK2 inhibitor, with IC50 values of 3.02 μM and 5.34 μM in MKN-1 and MOLT4 cells, respectively .
    RIOK2-IN-2
  • HY-156792
    RIOK2-IN-1

    		Ser/Thr Kinase Cancer
    RIOK2-IN-1 (com 4) is a potent and selective RIOK2 inhibitor (Kd=150 nM), but has low cellular activity (IC50=14,600 nM). RIOK2 is an atypical kinase associated with a variety of human cancers and is involved in ribosome maturation and cell cycle progression. The small molecule inhibitor CQ211 (HY-147655), an improvement of RIOK2-IN-1 as the lead compound, has good in vivo and in vitro activity, inhibits the proliferation of MKN-1 and HT-29 cancer cells, and can xenograft MKN in mice -1 model inhibits tumor progression .
    RIOK2-IN-1
  • HY-175733
    CQ3196

    		Ser/Thr Kinase Apoptosis Cancer
    CQ3196 is an orally active RIOK2 inhibitor with a Kd of 14 nM. CQ3196 effectively inhibits the ATPase activity of RIOK2, with an IC50 value of 72 nM. CQ3196 inhibits cell proliferation and colony formation in gastric cancer cell lines. CQ3196 induces cell apoptosis in HGC-27 and AGS cells. CQ3196 suppresses downstream signal pathway of RIOK2. CQ3196 reduces phosphorylation of mTOR and AKT. CQ3196 modulates ribosome function and protein synthesis. CQ3196 inhibits tumor growth and can be used for gastric cancer invtro and invivo research .
    CQ3196
  • HY-170574
    CQ627

    		Molecular Glues Ser/Thr Kinase Apoptosis Cancer
    CQ627 is a molecular glue targeting the degradation of RIOK2. It effectively induces the degradation of RIOK2 in the MOLT4 leukemia cell line via the ubiquitin-proteasome system (UPS) by recruiting the E3 ubiquitin ligase RNF126, with a DC50 value of 410 nM. CQ627 dose-dependently induces apoptosis in MOLT4 leukemia cells, blocks their cell cycle in the G2/M phase, and exhibits antiproliferative activities in various cancer cell lines. CQ627 also demonstrates in vivo anticancer activity in a MOLT4 xenograft mouse model .
    CQ627

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: